Madhuravasal Krishnan Janani, Jayaraman Dhaarani, Kancharla Adarsh, Thangam Aishwarya, Venkatramanan Padmasani, Scott Julius Xavier
Microbiology, Medical Research Foundation, Chennai, IND.
Pediatrics, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Cureus. 2023 Jan 3;15(1):e33314. doi: 10.7759/cureus.33314. eCollection 2023 Jan.
Background Neutropenic patients are commonly affected by respiratory infections, whereas respiratory viral infections causing high morbidity and mortality are routinely diagnosed in developing countries like India. Our study aimed to investigate the prevalence of respiratory viral infections in pediatric cancer patients with febrile neutropenia. Methods This prospective study was performed on 45 neutropenia patients with hematological malignancies. Nasal swabs were collected and analyzed by real-time multiplex polymerase chain reaction (PCR), covering the following viruses: influenza A virus, influenza B virus, human parainfluenza virus (subtypes 1-4), human respiratory syncytial virus A and B, enterovirus, human-coronavirus (HCoV: HKU1, NL63, 229E, and OC43), human bocavirus, adenovirus, human rhinovirus, human-metapneumovirus A and B, human paraechovirus, and a bacterium . Patients enrolled in the study since the COVID-19 pandemic was also detected for the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Results Of the 45 cases included in our study, 26 cases showed the presence of at least one positivity by PCR (57.7%): 23 patients had monoinfection with only one virus, two patients were found positive for coinfection with two viruses, and one patient was found positive for three viruses. The most detected viruses were human rhinovirus (26.9%, n=7) and coronavirus 19 (19.2%, n=5). A total of 11.5% of the patients had multiple viral infections. About 19 (42.2%) of the patients enrolled in our study had no viral pathogen detected. Conclusion We found that respiratory viruses contribute significantly to the development of neutropenic fever, as evidenced by the results of our prospective study. Individualizing infection treatment can reduce antibiotic use in immunocompromised patients. Thus, routine screening for viremia may be warranted in this clinical setting.
中性粒细胞减少患者常受呼吸道感染影响,而在印度等发展中国家,导致高发病率和死亡率的呼吸道病毒感染经常被诊断出来。我们的研究旨在调查发热性中性粒细胞减少的儿科癌症患者中呼吸道病毒感染的患病率。
对45例血液系统恶性肿瘤的中性粒细胞减少患者进行了这项前瞻性研究。收集鼻拭子并通过实时多重聚合酶链反应(PCR)进行分析,检测以下病毒:甲型流感病毒、乙型流感病毒、人副流感病毒(1 - 4型)、人呼吸道合胞病毒A和B、肠道病毒、人冠状病毒(HCoV:HKU1、NL63、229E和OC43)、人博卡病毒、腺病毒、人鼻病毒、人偏肺病毒A和B、人副埃可病毒,以及一种细菌。自新冠疫情以来纳入研究的患者还检测了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的存在。
在我们研究纳入的45例病例中,26例通过PCR显示至少一种阳性(57.7%):23例患者仅感染一种病毒,2例患者同时感染两种病毒呈阳性,1例患者同时感染三种病毒呈阳性。检测到最多的病毒是人鼻病毒(26.9%,n = 7)和冠状病毒19(19.2%,n = 5)。共有11.5%的患者有多种病毒感染。我们研究中约19例(42.2%)患者未检测到病毒病原体。
我们的前瞻性研究结果表明,呼吸道病毒在中性粒细胞减少性发热的发生中起重要作用。个体化感染治疗可减少免疫受损患者的抗生素使用。因此,在这种临床情况下,可能有必要对病毒血症进行常规筛查。